Tekmira Pharmaceuticals Corporation Cash Conversion Cycle
Tekmira Pharmaceuticals Corporation Cash Conversion Cycle Chart
Tekmira Pharmaceuticals Corporation Historical Cash Conversion Cycle DataPro Data Export
There is no data for the selected date range.
About Cash Conversion Cycle
The cash conversion cycle (CCC) is the theoretical amount of time between a company spending cash and receiving cash per each sale, output, unit of operation, etc. It is basically a measure of how long cash is tied up in working capital.
See a sample analysis using the cash conversion cycle.
View Cash Conversion Cycle for TKMR.
Start Your YCharts Pro Gold Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $49/month, and comes with a 14-day free trial.Get Started Now
Already a YCharts Pro Gold Member? Sign in here.
TKMR Cash Conversion Cycle Benchmarks
|Alnylam Pharmaceuticals||Go Pro|
|DelMar Pharmaceuticals||Go Pro|
TKMR Cash Conversion Cycle Rankings
1460 of 7590
116 of 651 in Healthcare
37 of 238 in Biotechnology
TKMR Cash Conversion Cycle Range, Past 5 Years
|Minimum||Go Pro||Sep 2010|
|Maximum||Go Pro||Mar 2011|
noodls May 17
GlobeNewswire May 15
Seeking Alpha May 14
GlobeNewswire May 14
GlobeNewswire May 8